Abby Sapp, DO
Gastroenterology · Rockport, MENPI 1538400247
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $827 of the $1,284 with a category attached, or 64.4%. 7 manufacturers reported payments, led by Boston Scientific at 58.9% of the total. Reporting peaked in 2019 at $895 and has fallen 76.9% since, to $207 in 2025.
Across 18 payments — averaging $71.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$756
- Covidien LP$202
- Janssen Scientific Affairs, LLC$127
- Digestive Care, Inc.$82
- AbbVie$71
- Phathom Pharmaceuticals, Inc.$26
- plus $21 from 1 others
What the payments were for
- Travel & lodging$45736%
- Food & beverage$82764%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 6 | $756 |
| Covidien LP | 3 | $202 |
| Janssen Scientific Affairs, LLC | 1 | $127 |
| Digestive Care, Inc. | 1 | $82 |
| AbbVie | 3 | $71 |
| Phathom Pharmaceuticals, Inc. | 3 | $26 |
| Johnson & Johnson | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,284 in reported general payments places this provider in the 65th percentile of 68 gastroenterology providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 74 | $1,496 |
| Sucralfate | 16 | $779 |
| Pantoprazole Sodium | 35 | $519 |
| Famotidine | 15 | $154 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Rockport
- Jon StaufferRockport$7K
- Steven RogersRockport$570
- Joseph MinissaleRockport$546
- Eric EltonRockport$145
- Kirk BernadinoRockport$117
- Douglas HowellPortland$1.2M
- Martin MoehlenPortland$340K
- Tahira SaifuddinBangor$84K
- Brian BerberianBangor$70K
- Janese LasterBangor$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.